Showing results (131-140 of 173) with videos related to
Sort By:
Pageof 18
British Journal of Haematology|May 30, 2018
Human Pegivirus infection and lymphoma risk and prognosis: a North American studyAngelo Fama, Jinhua Xiang, Brian K Link, et al.Cancer Causes & Control : CCC|May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaJennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.Leukemia & Lymphoma|November 9, 2016
Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practiceHeidi D Finnes, Kari G Chaffee, Timothy G Call, et al.British Journal of Haematology|August 18, 2018
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centrePaul J Hampel, Melissa C Larson, Brian Kabat, et al.Annals of Hematology|June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J Archibald, Kari G Rabe, Brian F Kabat, et al.Blood|November 15, 2008
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T Awan, Neil E Kay, Melanie E Davis, et al.American Journal of Hematology|December 22, 2018
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomesHong Fang, Kaaren K Reichard, Kari G Rabe, et al.The Lancet. Oncology|September 18, 2016
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre studySusan O'Brien, Jeffrey A Jones, Steven E Coutre, et al.American Journal of Hematology|September 24, 2017
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findingsPaul J Hampel, Kari G Chaffee, Rebecca L King, et al.Blood Cancer Journal|January 29, 2022
Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?Rebecca L King, Alia Gupta, Paul J Kurtin, et al.Pageof 18